FDA asks J&J's DePuy to recall unused custom implants

August 24, 2012 by MassDevice staff

Johnson & Johnson subsidiary DePuy Orthopedics recalls all unused custom implants, a product line the company discontinued after receiving an FDA warning letter late last year.

DePuy logo

Following an FDA request, Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics launched a recall of all unused units of its customer orthopedic implants, a product line the company shut down in January.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp